Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 31INDUSTRY 7NETWORK 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 30Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 18Lung Neoplasms 14Head and Neck Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Ovarian Neoplasms 7Carcinoma, Ovarian Epithelial 5Adenocarcinoma of Lung 5Inflammatory Breast Neoplasms 4Fallopian Tube Neoplasms 4Esophageal Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Salivary Gland Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms, Male 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Recurrent Uterine Corpus Sarcoma 2Recurrent Squamous Cell Lung Carcinoma 2Carcinoma 2Anatomic Stage I Breast Cancer AJCC v8 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1

Interventions

Gemcitabine 17Fluorouracil 8Capecitabine 6Radiotherapy 5Leucovorin 5Albumin-Bound Paclitaxel 5Taxes 4Irinotecan 4Cisplatin 4130-nm albumin-bound paclitaxel 4Specimen Handling 3Radiotherapy, Conformal 3Docetaxel 3irinotecan sucrosofate 2dehydroftorafur 2Surgical Procedures, Operative 2Radiosurgery 2Pancreaticoduodenectomy 2Chemotherapy, Adjuvant 2Cetuximab 2trametinib 1tipifarnib 1saracatinib 1pegfilgrastim 1lanreotide 1ganitumab 1durvalumab 1conatumumab 1beta-D-glucosylisophosphoramide mustard 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Pancreatic Neoplasms × Docetaxel × Clear all
NCT00042939 2023-07-06

Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
94 enrolled 10 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00003810 2023-06-15

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Eastern Cooperative Oncology Group

Phase 2 Completed
Gastrointestinal

Pancreatic Neoplasms

NCT00004884 2012-09-24

Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
96 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡